Comparing infusion-related reactions of the first full dose (600 mg) biosimilar ocrelizumab administration with the standard divided protocol in multiple sclerosis patients: a randomized controlled trial study
Abbasi Kasbi, Naghmeh, Ghadiri, F., Sahraian, M. A., Nahayati, M. A., Moghadasi, A. Naser, Langroodi, H. Ghalyanchi, Poursadeghfard, M., Hosseini, S., Heidari, H., Baghbanian, S. M., Kamali, H., Ameli, Z., Shahmohammadi, S., Navardi, S.
Published in Acta neurologica Belgica (01.02.2024)
Published in Acta neurologica Belgica (01.02.2024)
Get full text
Journal Article
Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA
Ghandehari, K, Zahed, A Pour, Taheri, M, Abbasi, M, Gorjestani, S, Ahmadi, A Moghaddam, Nahayati, M A
Published in International journal of stroke (01.08.2009)
Published in International journal of stroke (01.08.2009)
Get more information
Journal Article